BACKGROUND: Keloids are a common form of pathologic wound healing characterized by excessive production of extracellular matrix. The unfolded protein response (UPR) is a cellular response to hypoxia, a component of the wound microenvironment, capable of protecting cells from the effects of over-accumulation of misfolded proteins. Since keloids have hypersecretion of extracellular matrix, we hypothesized that keloid fibroblasts (KFs) may have enhanced activation of the UPR compared with normal fibroblasts (NFs). METHODS: KFs and NFs were placed in a hypoxia chamber for 0, 24, and 48h. We also used tunicamycin to specifically up-regulate the UPR. UPR activation was assayed by PCR for xbp-1 splicing and by immunoblotting with specific antibodies for the three UPR transducers. Nuclear localization of XBP-1 protein in KFs was confirmed by immunofluorescence. RESULTS: There is increased activation of XBP-1 protein in KFs compared with NFs following exposure to hypoxia. Pancreatic ER kinase (PERK) and ATF-6, two other pathways activated by the UPR, show comparable activation between KFs and NFs. We confirmed that there is enhanced activation of XBP-1 by demonstrating increased nuclear localization of XBP-1 using immunofluorescence. CONCLUSION: In contrast to our initial hypothesis that keloids would have broad activation of the UPR, we demonstrate here that there is a specific up-regulation of one facet of the UPR response. This may represent a specific molecular defect in KFs compared with NFs, and also suggests modulation of the UPR can be used in wound healing therapy. Published by Elsevier Inc.
BACKGROUND: Keloids are a common form of pathologic wound healing characterized by excessive production of extracellular matrix. The unfolded protein response (UPR) is a cellular response to hypoxia, a component of the wound microenvironment, capable of protecting cells from the effects of over-accumulation of misfolded proteins. Since keloids have hypersecretion of extracellular matrix, we hypothesized that keloid fibroblasts (KFs) may have enhanced activation of the UPR compared with normal fibroblasts (NFs). METHODS: KFs and NFs were placed in a hypoxia chamber for 0, 24, and 48h. We also used tunicamycin to specifically up-regulate the UPR. UPR activation was assayed by PCR for xbp-1 splicing and by immunoblotting with specific antibodies for the three UPR transducers. Nuclear localization of XBP-1 protein in KFs was confirmed by immunofluorescence. RESULTS: There is increased activation of XBP-1 protein in KFs compared with NFs following exposure to hypoxia. Pancreatic ER kinase (PERK) and ATF-6, two other pathways activated by the UPR, show comparable activation between KFs and NFs. We confirmed that there is enhanced activation of XBP-1 by demonstrating increased nuclear localization of XBP-1 using immunofluorescence. CONCLUSION: In contrast to our initial hypothesis that keloids would have broad activation of the UPR, we demonstrate here that there is a specific up-regulation of one facet of the UPR response. This may represent a specific molecular defect in KFs compared with NFs, and also suggests modulation of the UPR can be used in wound healing therapy. Published by Elsevier Inc.
Authors: Zhen Wang; Kenton D Fong; Toan-Thang Phan; Ivor J Lim; Michael T Longaker; George P Yang Journal: J Cell Physiol Date: 2006-02 Impact factor: 6.384
Authors: C S Nirodi; R Devalaraja; L B Nanney; S Arrindell; S Russell; J Trupin; A Richmond Journal: Wound Repair Regen Date: 2000 Sep-Oct Impact factor: 3.617
Authors: Tatiana V Boyko; Rakesh Bam; Dadi Jiang; Zhen Wang; Namrata Bhatia; Misha C Tran; Michael T Longaker; Albert C Koong; George P Yang Journal: Wound Repair Regen Date: 2018-02-06 Impact factor: 3.617
Authors: Javier Barallobre-Barreiro; Elizabeth Woods; Rachel E Bell; Jennifer A Easton; Carl Hobbs; Michael Eager; Ferheen Baig; Alastair Mackenzie Ross; Raj Mallipeddi; Barry Powell; Mark Soldin; Manuel Mayr; Tanya J Shaw Journal: Matrix Biol Plus Date: 2019-10-30
Authors: Yan Hu; Yingfeng Shi; Hui Chen; Min Tao; Xun Zhou; Jinqing Li; Xiaoyan Ma; Yi Wang; Na Liu Journal: Front Immunol Date: 2022-03-02 Impact factor: 7.561